Global Retirement Partners LLC Sells 162 Shares of Agilent Technologies, Inc. (NYSE:A)

Global Retirement Partners LLC trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 6.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,408 shares of the medical research company’s stock after selling 162 shares during the period. Global Retirement Partners LLC’s holdings in Agilent Technologies were worth $324,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the stock. Kentucky Retirement Systems Insurance Trust Fund grew its stake in shares of Agilent Technologies by 35.6% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 11,714 shares of the medical research company’s stock valued at $1,574,000 after buying an additional 3,076 shares in the last quarter. Cardinal Capital Management grew its position in shares of Agilent Technologies by 0.3% in the 4th quarter. Cardinal Capital Management now owns 68,764 shares of the medical research company’s stock valued at $9,255,000 after acquiring an additional 213 shares during the period. Venturi Wealth Management LLC grew its position in shares of Agilent Technologies by 53.9% in the 4th quarter. Venturi Wealth Management LLC now owns 805 shares of the medical research company’s stock valued at $108,000 after acquiring an additional 282 shares during the period. D.A. Davidson & CO. increased its stake in shares of Agilent Technologies by 79.3% during the 4th quarter. D.A. Davidson & CO. now owns 7,267 shares of the medical research company’s stock worth $976,000 after purchasing an additional 3,214 shares during the last quarter. Finally, CIBC Asset Management Inc raised its holdings in shares of Agilent Technologies by 2.7% in the 4th quarter. CIBC Asset Management Inc now owns 44,315 shares of the medical research company’s stock valued at $5,953,000 after purchasing an additional 1,157 shares during the period.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Agilent Technologies Trading Down 0.1 %

Shares of A stock opened at $135.19 on Tuesday. The stock has a market cap of $38.57 billion, a P/E ratio of 30.58, a price-to-earnings-growth ratio of 3.67 and a beta of 1.07. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The stock has a 50 day simple moving average of $140.92 and a 200 day simple moving average of $139.33.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company’s revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.38 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.73%. Agilent Technologies’s dividend payout ratio is 22.40%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on A. Bank of America lowered their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Wells Fargo & Company decreased their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Sanford C. Bernstein reduced their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Finally, StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $144.38.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.